Search Results 21 – 40 of 105
Initiation of Antiretroviral Therapy
Cryptococcosis
Cryptosporidiosis
Antiretroviral Therapy to Prevent Sexual Transmission of HIV (Treatment as Prevention)
Cytomegalovirus
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
What to Start: Initial Combination Antiretroviral Regimens
What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios
What to Start: Nucleoside Reverse Transcriptase Inhibitor Options
What to Start: Integrase Strand Transfer Inhibitor Regimens
What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
What to Start: Protease Inhibitor–Based Regimens
What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal
What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy
Giardiasis
Management of People With HIV and Antiretroviral Therapy Experience
Hepatitis B Virus
Virologic Failure
Poor CD4 Cell Recovery and Persistent Inflammation Despite Viral Suppression
Optimizing Antiretroviral Therapy in the Setting of Virologic Suppression